3Turner HE,Nagy Z,Esiri MM, et al. Role of matrix metalloproteinase 9 in pituitary tumor behavior[J]. J Clin Endocrinol Metab, 2000,85 ( 8 ) : 2931-2935.
4Sato F, Shimada Y, Watanabe G, et al. expression of vascular endothelial growth factor, matrix metalloproteinase-9 and Ecadherin in the process of lymph node metastasis in oesophageal cancer[J]. Br J Cancer, 1999, 80(9):1366-1372.
5Hedinger C,Williams ED,Sobin LH,et al. The WHO histological classification of thyroid tumors:a commentary on the second edition[J]. Cancer, 1989,63:908-911.
6Weidner N, Semple JP, Welliam WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med,1991,324:1-8.
7Kossakowska AE,Huchcroft SA,Urbanski SJ,et d. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia,sporadic colorectal neopalsia,pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans[J]. Br J Cancer, 1996,73:1401-1408.
8Wong NA, Willott J, Kendall M J, et al.measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid turnouts:comparison of different methods of assessing vascular[J]. J Clin Pathol, 1999,52:593-597.
4Turner HE, Nagy Z, Esiri MM, et al. Role of matrix metalloproteinase 9 in pituiary tumor behavior [J]. J Clin Endocrinol Metab, 2000;85(8):2931～2935.
5SatoF, Shimada Y, Watanabe G, etal. Expression of vascular endothelial growth factor, matrix metalloproteinase - 9 and E- cadherin in the process of lymph node metastasis in oesophageal cancer [J]. Br J Cancer,1999;80(9):1366～1372.
6Hedinger C, Williams ED, Sobin LH, et al. The WHO histological classification of thyroid tumors: a commentary on the second edition [J].Cacner, 1989;63:908～911.
7Kleiner DE, Stetler- Stevenson WG. Quantitative zymography: detection of picogran quantities of gelatinases [J]. Anal biochem, 1994;218:325～325.
8Parsons SL, Waston SA, Collins HM, et al. Gelatinase (MMP- 2 and MMP-9) expression in gastrointestinal malignancy [J]. Br J Cancer,1998;78(11):1496～1498.
9Hofmnn A, LaueS, RostAK, etal. mRNA levels of memberane - typel matrix metalloproteinases (MT1 - MMP), MMP - 2 and MMP - 9 and of their inhibitors TIMP - 2 nd TIMP - 3 in normal thyrocytes and thyroid carcinboma cells lines [J]. Thyoid, 1998;8(3):203～214.
10Nakamura H, Ueno H, Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane- type 1 matrix metallo-proteinase in human papillary thyroid carcinomas [J]. Cancer Research,1999;59(2):467～473.
